MacroGenics (MGNX) exec adds 40K shares via option exercise
Rhea-AI Filing Summary
MACROGENICS INC (MGNX) reported that Sr VP, Research & CSO Ezio Bonvini40,000 shares at $2.60 per share on 2026-08-17. This option exercise converted into 40,000 shares of Common Stock in an exercise-and-hold transaction. Following the transaction, Bonvini directly holds 185,799 shares of Common Stock and 88,000 Employee Stock Options with an exercise price of $2.60 per share expiring on 2035-02-07. Footnotes indicate a staggered vesting schedule for the option grant.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 40,000 shares
Net Buy
2 txns
Insider
Bonvini Ezio
Role
Sr VP, Research & CSO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) F2 | 40,000 | $2.60 | $104K |
| Exercise | Common Stock F1 | 40,000 | $2.60 | $104K |
Holdings After Transaction:
Employee Stock Option (right to buy) — 88,000 shares (Direct);
Common Stock — 185,799 shares (Direct)
Footnotes (2)
- F1. The transaction represents an exercise and hold of options.
- F2. 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
Key Figures
Options Exercised: 40,000 shares
Exercise Price: $2.60 per share
Common Shares Owned After: 185,799 shares
+3 more
6 metrics
Options Exercised
40,000 shares
Employee Stock Option (right to buy) exercised on 2026-08-17
Exercise Price
$2.60 per share
Exercise price for 40,000 Employee Stock Options
Common Shares Owned After
185,799 shares
Directly owned Common Stock following the 2026-08-17 transaction
Options Held After
88,000 options
Employee Stock Options remaining after the reported exercise
Option Expiration Date
2035-02-07
Expiration date of the Employee Stock Option grant exercised in part
Transaction Date
2026-08-17
Date of option exercise and resulting share acquisition
Key Terms
Employee Stock Option (right to buy), derivative security, exercise and hold
3 terms
Employee Stock Option (right to buy) financial
"security_title: "Employee Stock Option (right to buy)""
derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
exercise and hold financial
"footnote: "The transaction represents an exercise and hold of options.""
FAQ
What insider transaction did MGNX executive Ezio Bonvini report on this Form 4?
Ezio Bonvini reported exercising 40,000 Employee Stock Options at $2.60 per share, receiving 40,000 shares of MacroGenics Common Stock. The transaction is characterized as an exercise-and-hold, meaning the acquired shares were retained rather than sold.
What options did Ezio Bonvini exercise in MacroGenics (MGNX) and at what price?
Bonvini exercised 40,000 Employee Stock Options in MacroGenics at an exercise price of $2.60 per share. These options relate to a grant where vesting is staggered over time, and the options carry an expiration date of 2035-02-07.
How many MacroGenics (MGNX) stock options does Ezio Bonvini hold after the exercise?
Following the reported exercise, Bonvini holds 88,000 Employee Stock Options with an exercise price of $2.60 per share. These options are scheduled to expire on 2035-02-07, and they continue to vest according to the grant’s specified vesting schedule.
AI-generated analysis. How Rhea-AI works. Not financial advice.
